Zumiez Inc.

ZUMZ

CIK 0001318008 · Quarterly mode · latest period FY2026 (Q4) (ending 2026-01-31) · sourced from SEC EDGAR

At a glance · FY2026 (Q4)

Revenue
$291M
↑+4.4% +$12Mvs FY2025 (Q1)
Operating Income
$5M
↓-63.6% -$9Mvs FY2025 (Q1)
Net Income
$4M
Gross Profit
$111M
↑+10.3% +$10Mvs FY2025 (Q1)

Quality Score

Quality score

6-dimension fundamental snapshot · latest annual filed values · S&P 500 calibration

Strong
66/100
  • Profitability
    0ROIC 2.9% (10% = solid, 20%+ = moat)
  • Liquidity
    75Current Ratio 2.01 (above 1.5 = solid)
  • Leverage
    100D/E 0.01 (under 0.5 = conservative)
  • Efficiency
    96Asset Turnover 1.45x (1.0+ = capital-efficient)
  • Growth
    31Revenue YoY +4.4% (10% = solid, 25%+ = elite)
  • Margin Trend
    92Op Margin 1.8% · trend +2.5pts (4Q avg vs prior 4Q)

Calibrated to S&P 500 medians. Each sub-score is computed from a single CFA-grade ratio (Profitability = ROIC, Liquidity = Current Ratio, Leverage = D/E, Efficiency = Asset Turnover, Growth = Revenue YoY, Margin Trend = 4Q operating-margin avg vs prior 4Q). Overall = simple mean.

DCF intrinsic value

DCF intrinsic value

two-stage Gordon model

Project ZUMZ's free cash flow forward, discount back at your hurdle rate, divide by diluted shares. Edit the assumptions to see how sensitive the intrinsic value is.

8%

Trailing CAGR unavailable; default 8%

10%

10% is a common all-equity benchmark for US large-caps

2.5%

Should be ≤ long-run GDP growth (~2.5% nominal)

5

5-year explicit projection + perpetuity terminal

Intrinsic value per share
$42.30
Total enterprise IV
$730M
Diluted shares
0.02B
Terminal PV
$529M (72% of total)
Year-5 FCF
$62M
YearProjected FCFDiscounted PV
+1$46M$42M
+2$49M$41M
+3$53M$40M
+4$58M$39M
+5$62M$39M
Terminal$852M$529M

DCF outputs are HIGHLY sensitive to growth + WACC assumptions. A 1pp WACC change can shift IV by 20%+. Use this as a sanity-check vs market price, not a target — and always cross-check the underlying FCF source (EDGAR cashflow statement, latest annual). Margin of safety convention: 30-50% discount to IV before buying.

Capital allocation · trailing 4 quarters

how the company spent its cash
Capex (TTM)
$11M
investment in PP&E
Stock buybacks (TTM)
$38M
share count reduction
Stock-based comp (TTM)
$7M
non-cash dilution

Balance sheet · 2026-01-31

latest filed snapshot
Total assets
$644M
everything owned
Total liabilities
$320M
everything owed
Stockholders' equity
$324M
shareholder claim
Net debt
$-126M
Net cash position ($126M)

Recent performance · 64 quarters

Revenue↑+4.4% +$12M
$291M
Net Income
$4M
Free Cash Flow↑+8.9% +$4M
$54M
Operating Margin
1.8%

Drill down